<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Case Rep</journal-id>
      <journal-id journal-id-type="publisher-id">amjcaserep</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1941-5923</issn>
      <publisher>
        <publisher-name>International Scientific Literature, Inc.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27287959</article-id>
      <article-id pub-id-type="pmc">4917065</article-id>
      <article-id pub-id-type="doi">10.12659/AJCR.897900</article-id>
      <article-id pub-id-type="publisher-id">897900</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Benign Hydronephrosis and Elevated of Serum Levels of Carbohydrate Antigen CA 19-9: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Filipovic</surname>
            <given-names>Branka</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1-amjcaserep-17-395">
            <sup>A</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-17-395">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-17-395">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="c1-amjcaserep-17-395"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Milini&#x107;</surname>
            <given-names>Nikola</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1-amjcaserep-17-395">
            <sup>A</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-17-395">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-17-395">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gacic</surname>
            <given-names>Jasna</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn2-amjcaserep-17-395">
            <sup>B</sup>
          </xref>
          <xref ref-type="aff" rid="af3-amjcaserep-17-395">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Markovic</surname>
            <given-names>Olivera</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn4-amjcaserep-17-395">
            <sup>D</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-17-395">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="af4-amjcaserep-17-395">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Djokovic</surname>
            <given-names>Aleksandra</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-17-395">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-17-395">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="af5-amjcaserep-17-395">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Filipovic</surname>
            <given-names>Branislav</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-17-395">
            <sup>E</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-17-395">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="af6-amjcaserep-17-395">
            <sup>6</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="af1-amjcaserep-17-395"><label>1</label>Department of Gastroenterohepatology, Clinical and Hospital Center &#x201C;Bezanijska Kosa&#x201D;, Belgrade, Serbia</aff>
      <aff id="af2-amjcaserep-17-395"><label>2</label>Faculty of Medicine, University of Belgrade, Belgrade, Serbia</aff>
      <aff id="af3-amjcaserep-17-395"><label>3</label>Department of Surgery, Clinical and Hospital Center &#x201C;Bezanijska Kosa&#x201D;, Belgrade, Serbia</aff>
      <aff id="af4-amjcaserep-17-395"><label>4</label>Department of Hematology, Clinical and Hospital Center &#x201C;Bezanijska Kosa&#x201D;, Belgrade, Serbia</aff>
      <aff id="af5-amjcaserep-17-395"><label>5</label>Department of Cardiology, Clinical and Hospital Center &#x201C;Bezanijska Kosa&#x201D;, Belgrade, Serbia</aff>
      <aff id="af6-amjcaserep-17-395"><label>6</label>Institute of Anatomy &#x201C;Niko Miljanic&#x201D;, Belgrade, Serbia</aff>
      <author-notes>
        <fn>
          <p>Authors&#x2019; Contribution:</p>
        </fn>
        <fn id="fn1-amjcaserep-17-395">
          <label>A</label>
          <p>Study Design</p>
        </fn>
        <fn id="fn2-amjcaserep-17-395">
          <label>B</label>
          <p>Data Collection</p>
        </fn>
        <fn id="fn3-amjcaserep-17-395">
          <label>C</label>
          <p>Statistical Analysis</p>
        </fn>
        <fn id="fn4-amjcaserep-17-395">
          <label>D</label>
          <p>Data Interpretation</p>
        </fn>
        <fn id="fn5-amjcaserep-17-395">
          <label>E</label>
          <p>Manuscript Preparation</p>
        </fn>
        <fn id="fn6-amjcaserep-17-395">
          <label>F</label>
          <p>Literature Search</p>
        </fn>
        <fn id="fn7-amjcaserep-17-395">
          <label>G</label>
          <p>Funds Collection</p>
        </fn>
        <fn id="fn8-amjcaserep-17-395">
          <p><bold>Conflict of interest:</bold> None declared</p>
        </fn>
        <fn id="fn9-amjcaserep-17-395">
          <p><bold>Source of suport:</bold> The investigation has been partially financed by the Ministry of Education, Science, and Technological Development of the Republic of Serbia, No III 41020</p>
        </fn>
        <corresp id="c1-amjcaserep-17-395">Corresponding Author: Branka Filipovic, e-mail: <email>branka.filipovic3@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <volume>17</volume>
      <fpage>395</fpage>
      <lpage>397</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>2</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Am J Case Rep, 2016</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
          <bold>Patient: Male, 58</bold>
        </p>
        <p>
          <bold>Final Diagnosis: Hydronephrosis</bold>
        </p>
        <p>
          <bold>Symptoms: Blunt abdominal pain &#x2022; constipation &#x2022; constipation</bold>
        </p>
        <p>
          <bold>Medication: &#x2014;</bold>
        </p>
        <p>
          <bold>Clinical Procedure: Extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy</bold>
        </p>
        <p>
          <bold>Specialty: Gastroenterology and Hepatology</bold>
        </p>
        <sec>
          <title>Objective:</title>
          <p>
            <bold>Rare co-existance of disease or pathology</bold>
          </p>
        </sec>
        <sec>
          <title>Background:</title>
          <p>Carbohydrate tumor-associated antigen (CA 19-9) has been shown to be upregulated in other malignant tumors including gastric, ovarian, hepatocellular, and colorectal carcinoma as well as benign diseases of the biliary track such as pancreatitis, cholangitis, and choledocholithiasis. According to the available literature, in several cases of benign hydronephrosis and in a few cases of benign renal diseases, elevated CA 19-9 has been noted.</p>
        </sec>
        <sec>
          <title>Case Report:</title>
          <p>A 58-year-old Caucasian male patient was admitted in our clinic with complaints about blunt abdominal pain in the past two-month period localized in the right lumbar region and irradiating into the right inguinal area, constipation, abdominal bloating, and intermittent hematuria.</p>
          <p>The concentration of serum CA 19-9 was 3500 U/mL. Urine cytology provided no signs of abnormality. Intravenous urography visualized right-sided pyelon and ureter duplex with the defect in contrast shade of the pyelon, caused by a stag horn calculus. Contrast added computerized axial tomography of the abdomen and pelvis visualized the pyelon casted concretion spreading throughout the right pyelon, with ureterohydronephrosis with the distal block for passage of the contrast to the distal part of the ureter.</p>
        </sec>
        <sec>
          <title>Conclusions:</title>
          <p>There is no doubt that CA 19-9 level is occasionally elevated in patients with obstructive urolithiasis as it was in our case. In the routine medical praxis, urolithiasis should not be neglected in the differential diagnosis of elevated concentrations of CA 19-9 marker.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>MeSH Keywords</title>
        <kwd>CA-19-9 Antigen</kwd>
        <kwd>Hydronephrosis</kwd>
        <kwd>Kidney Calculi</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Carbohydrate tumor-associated antigen 19-9 (CA 19-9) is a 36-kDa glycolipid that is a sensitive, specific tumor marker for pancreatic, gastric, and hepatobiliary malignancies [<xref rid="b1-amjcaserep-17-395" ref-type="bibr">1</xref>&#x2013;<xref rid="b4-amjcaserep-17-395" ref-type="bibr">4</xref>]. However, CA 19-9 has also been shown to be upregulated in other malignant tumors including gastric, ovarian, hepatocellular, and colorectal carcinoma, as well as benign diseases of the biliary track such as pancreatitis, cholangitis, and choledocholithiasis [<xref rid="b5-amjcaserep-17-395" ref-type="bibr">5</xref>&#x2013;<xref rid="b7-amjcaserep-17-395" ref-type="bibr">7</xref>]. According to the available literature, in several cases of benign hydronephrosis and in a few cases of benign renal diseases, elevated CA 19-9 has been noted [<xref rid="b8-amjcaserep-17-395" ref-type="bibr">8</xref>,<xref rid="b9-amjcaserep-17-395" ref-type="bibr">9</xref>].</p>
      <p>In this paper, the authors discuss another case of benign, ureteric calculi induced hydronephrosis, associated with elevated serum level of CA 19-9.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A 58-year-old Caucasian male patient was admitted to our clinic with the complaints about blunt abdominal pain in the past two-month period localized in the right lumbar region and irradiating into the right inguinal area, constipation, abdominal bloating, and intermittent hematuria. His medical history involved repetitive nephrolithiasis that was, on admission, in the phase of acute worsening.</p>
      <p>On admittance, the patient&#x2019;s general physical examination revealed a solid, elastic palpable mass and remarkable tenderness in the right lumbar region. His family history anamnesis was positive for the presence of the pancreatic cancer. The routine laboratory parameters were found to be in the normal ranges, except markers of inflammation (erythrocyte sedimentation rate 90 mm at the end of the first hour, C-reactive protein 46 mg/L, plasma fibrinogen 6 g/L) and biochemical signs for a mild renal failure (serum creatinine concentration: 150 &#x3BC;mol/L, blood urea level of 10 mmol/L). The urine culture was negative for bacterial presence. Urine PH was less than 5.5. The concentration of CA 19-9 was 3500 U/mL. Urine cytology provided no signs of abnormality. Plain abdominal radiography showed a radio-opaque shadowing in the right kidney that appeared to be a partial stag horn calculus. Intravenous urography, ordered by the experienced urologist-operator, showed ureterohydronephrosis with the distal block for passage of the contrast, caused by a stag horn calculus. Also, there was defect in the contrast shade of the pyelon (<xref ref-type="fig" rid="f1-amjcaserep-17-395">Figure 1</xref>). Contrast added computerized axial tomography of the abdomen and pelvis visualized the pyelon casted concretion spreading throughout the right pyelon, with ureterohydronephrosis with the distal block for passage of the contrast to the distal part of the ureter (<xref ref-type="fig" rid="f2-amjcaserep-17-395">Figure 2</xref>). No sign of morphological abnormalities was detected in the liver, gall bladder, pancreas, or in the genitourinary tract. Ileocolonoscopy did not reveal any kind of pathological changes. Cystoscopy revealed four, small yellowish concrements in the bladder. Right retrograde pyelography exhibited shade defect of about 4 mm in the distal part of the right ureter, which appeared to be caused by radiolucent stones. Excretory urography revealed no significant excretion from the right kidney, indicating the lack of renal function.</p>
      <p>The patient was successfully treated by a combined treatment of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy. Stones fragments were spontaneously eliminated. The patient was free of urolithiasis two months after treatment. His renal function completely recovered and the serum CA 19-9 level and all laboratory parameters of inflammation were reduced to the normal range after removal of the stones, and the patient had no recurrence to the time of the report.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>In this case report, the authors present a unique case of renal hydronephrosis associated with elevated serum concentration of CA 19-9, the first case reported so far in this area of Europe. An association of benign urological disease associated with elevated CA 19-9 levels have already been described. Suzuki et al. [<xref rid="b8-amjcaserep-17-395" ref-type="bibr">8</xref>] have revealed increased serum levels of CA 19-9 in one fourth of 68 patients (123 serum samples) with benign hydronephrosis. The inflammation and subsequent damage of the urinary epithelium, obstruction of the CA 19-9 discharge pathway, and dysfunction of the organs that metabolize CA 19-9 results in elevation of CA 19-9 serum levels [<xref rid="b8-amjcaserep-17-395" ref-type="bibr">8</xref>,<xref rid="b9-amjcaserep-17-395" ref-type="bibr">9</xref>].</p>
      <p>Immunohistochemical studies demonstrated that Ca 19-9 was expressed in the renal tubular epithelium as well as in the urothelium of the renal pelvis, whereas other cells were not positive for the anti-CA 19-9 antibody [<xref rid="b9-amjcaserep-17-395" ref-type="bibr">9</xref>&#x2013;<xref rid="b11-amjcaserep-17-395" ref-type="bibr">11</xref>]. The mechanism of abnormal elevations in serum CA 19-9 in patients with benign hydronephrosis is, however, not clear. The excessive production of CA 199 &#x2013; in the renal pelvic mucosa may result from long-term chronic inflammation secondary to hydronephrosis, or CA 19-9 may be synthesized in the renal pelvic membrane and released into the circulation by an increase in the internal pressure of the renal pelvis due to the hydronephrosis [<xref rid="b11-amjcaserep-17-395" ref-type="bibr">11</xref>&#x2013;<xref rid="b14-amjcaserep-17-395" ref-type="bibr">14</xref>]. On the other hand, some authors have suggested that the relationship between CA 19-9 values and hydronephrosis was not found to be statistically meaningful and that there is no predictive importance of CA 19-9 as the parameter of urinary obstruction [<xref rid="b14-amjcaserep-17-395" ref-type="bibr">14</xref>].</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>There is no doubt that CA 19-9 level is occasionally elevated in patients with obstructive urolithiasis as it was in our case. In the routine medical praxis, urolithiasis should not be neglected in the differential diagnosis of elevated concentrations of CA 19-9 marker.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References:</title>
      <ref id="b1-amjcaserep-17-395">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qin</surname>
              <given-names>XL</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>ZR</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA</article-title>
          <source>World J Gastroenterol</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>4274</fpage>
          <lpage>32</lpage>
        </element-citation>
      </ref>
      <ref id="b2-amjcaserep-17-395">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katsanos</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Kitsanou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Christodoulou</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Tsianos</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
          <article-title>High CA 19-9 levels in benign bilary tract disease. Report of four cases and review of the literature</article-title>
          <source>Eur J Intern Med</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>1321</fpage>
          <lpage>35</lpage>
        </element-citation>
      </ref>
      <ref id="b3-amjcaserep-17-395">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waraya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Katagiri</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer</article-title>
          <source>Ann Surg Oncol</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>1231</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">19263172</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-amjcaserep-17-395">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnostic accuracy of serum CA19-9 in patients with cholangiocarcinoma</article-title>
          <source>Med Sci Monit</source>
          <year>2015</year>
          <volume>21</volume>
          <fpage>3555</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">26576628</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-amjcaserep-17-395">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheen-Chen</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extremely elevated CA19-9 in acute cholangitis</article-title>
          <source>Dig Dis Sci</source>
          <year>2007</year>
          <volume>52</volume>
          <fpage>3140</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">17404889</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-amjcaserep-17-395">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ong</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Sachdeva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Garcea</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration</article-title>
          <source>Dig Dis Sci</source>
          <year>2008</year>
          <volume>53</volume>
          <fpage>3213</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="pmid">18465243</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-amjcaserep-17-395">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris-Stiff</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Teli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jardine</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Puntis</surname>
              <given-names>MCA</given-names>
            </name>
          </person-group>
          <article-title>CA 19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease</article-title>
          <source>Hepatobiliary Pancreat Dis</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>620</fpage>
          <lpage>26</lpage>
        </element-citation>
      </ref>
      <ref id="b8-amjcaserep-17-395">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Muraishi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Tokue</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis</article-title>
          <source>J Urol</source>
          <year>2002</year>
          <volume>167</volume>
          <fpage>16</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">11743265</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-amjcaserep-17-395">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kausch</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kruger</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Elevation of Ca 19-9 in giant hydronephrosis induced by a renal calculus</article-title>
          <source>Urology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>381</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">14972505</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-amjcaserep-17-395">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shudo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Giant hydronephrosis due to a ureteral stone, and elevated serum levels of CA 19-9</article-title>
          <source>Inter Med</source>
          <year>1999</year>
          <volume>38</volume>
          <fpage>8878</fpage>
          <lpage>91</lpage>
        </element-citation>
      </ref>
      <ref id="b11-amjcaserep-17-395">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aybek</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aybek</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sinik</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis</article-title>
          <source>Int J Urol</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>1380</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">17083387</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-amjcaserep-17-395">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Giant hydronephrosis with increased carbohydrate antigen 19-9 both in serum and fluid</article-title>
          <source>Hinyokika Kiyuo</source>
          <year>2004</year>
          <volume>50</volume>
          <fpage>485</fpage>
          <lpage>88</lpage>
        </element-citation>
      </ref>
      <ref id="b13-amjcaserep-17-395">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akg&#xFC;l</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nuho&#x123;lu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ayyildiz</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Do hydronephrosis and extracorporal shock wave lithotripsy affect carbohydrate antigens?</article-title>
          <source>Int Urol Nephrol</source>
          <year>2007</year>
          <volume>39</volume>
          <fpage>1001</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">17334832</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-amjcaserep-17-395">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kutlu</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Celik</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Koksal</surname>
              <given-names>IT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Serum carbohydrate antigen 19-9 levels in patients with unilateral hydronephrosis due to urinary lithiasis</article-title>
          <source>Minerva Urol Nefrol</source>
          <year>2012</year>
          <volume>64</volume>
          <fpage>217</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">22971687</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-amjcaserep-17-395" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Intravenous pyelogram of the right kidney. (1) Dilated pyelon and initial part of the ureter. (2) Shadow of the double pelvis and ureter on the right side, adjacent to pyelon with calculosis.</p>
      </caption>
      <graphic xlink:href="amjcaserep-17-395-g001"/>
    </fig>
    <fig id="f2-amjcaserep-17-395" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>CT scans of abdomen. Arrows are marking the position of the kidney stone.</p>
      </caption>
      <graphic xlink:href="amjcaserep-17-395-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
